BriaCell Therapeutics Corp. (TSE:BCT – Get Free Report)’s stock price dropped 9% during mid-day trading on Friday. The company traded as low as C$4.80 and last traded at C$4.88. 15,457 shares changed hands during mid-day trading, a decline of 2% from the average session volume of 15,722 shares. The stock had previously closed at C$5.36.
BriaCell Therapeutics Trading Down 9.0%
The stock has a market cap of C$42.46 million, a PE ratio of -5.81 and a beta of 1.88. The business’s 50-day moving average price is C$5.31 and its 200-day moving average price is C$5.15.
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to developing novel immunotherapies to fight cancer and improve patients’ lives. Immunotherapies have become the forefront of the fight against cancer because they use the body’s immune system to destroy cancer cells, offer the potential for higher levels of safety and efficacy than chemotherapy, and may also prevent cancer recurrence.
See Also
- Five stocks we like better than BriaCell Therapeutics
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
